Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023.
Saved in:
| Title: | Emergence of Acquired HIV Drug Resistance Among Individuals Receiving Dolutegravir-Based Antiretroviral Therapy in Uganda: A National Laboratory-Based Survey 2023. |
|---|---|
| Authors: | Asio JN; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Watera C; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Namayanja G; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., da Silva JF; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Pals S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Ssemwanga D; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Sanyu G; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Nannyonjo M; Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda., Kaganda UK; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Busobozi R; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Nansumba H; Central Public Health Laboratories, Kampala, Uganda., Nabukenya M; Central Public Health Laboratories, Kampala, Uganda., Ayitewala A; Central Public Health Laboratories, Kampala, Uganda., Ssali M; Ministry of Health, Kampala, Uganda., Katureebe C; Ministry of Health, Kampala, Uganda., Magongo EN; Ministry of Health, Kampala, Uganda., Balidawa H; Ministry of Health, Kampala, Uganda., Nazziwa E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Ntale J; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Raizes E; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Zheng DP; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Zeh C; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Hackett S; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA., Naluguza M; Division of Global HIV & TB, U.S. Centers for Disease Control and Prevention, Kampala, Uganda., Mbidde EK; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda., Kaleebu P; Department of General Virology, Uganda Virus Research Institute (UVRI), Entebbe, Uganda.; Medical Research Council (MRC)/UVRI & London School of Hygiene and Tropical Medicine (LSHTM) Uganda Research Unit, Entebbe, Uganda. |
| Source: | Open forum infectious diseases [Open Forum Infect Dis] 2025 Nov 06; Vol. 12 (12), pp. ofaf679. Date of Electronic Publication: 2025 Nov 06 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Published by Oxford University Press on behalf of the Infectious Diseases Society of America Country of Publication: United States NLM ID: 101637045 Publication Model: eCollection Cited Medium: Print ISSN: 2328-8957 (Print) Linking ISSN: 23288957 NLM ISO Abbreviation: Open Forum Infect Dis Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2328-8957 |
|---|---|
| DOI: | 10.1093/ofid/ofaf679 |
